1. Home
  2. FVRR vs GYRE Comparison

FVRR vs GYRE Comparison

Compare FVRR & GYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fiverr International Ltd. no par value

FVRR

Fiverr International Ltd. no par value

HOLD

Current Price

$21.43

Market Cap

754.2M

ML Signal

HOLD

Logo Gyre Therapeutics Inc.

GYRE

Gyre Therapeutics Inc.

HOLD

Current Price

$7.77

Market Cap

755.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FVRR
GYRE
Founded
2010
2002
Country
Israel
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
754.2M
755.7M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
FVRR
GYRE
Price
$21.43
$7.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
2
Target Price
$32.60
$17.00
AVG Volume (30 Days)
727.8K
52.7K
Earning Date
11-05-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
139.40
N/A
EPS
0.61
0.04
Revenue
$427,401,000.00
$107,265,000.00
Revenue This Year
$12.77
$11.59
Revenue Next Year
$5.67
$26.31
P/E Ratio
$35.46
$201.07
Revenue Growth
12.68
2.13
52 Week Low
$19.36
$6.11
52 Week High
$36.11
$14.42

Technical Indicators

Market Signals
Indicator
FVRR
GYRE
Relative Strength Index (RSI) 51.47 53.20
Support Level $20.43 $7.36
Resistance Level $21.37 $7.95
Average True Range (ATR) 0.63 0.34
MACD 0.19 0.00
Stochastic Oscillator 76.39 47.75

Price Performance

Historical Comparison
FVRR
GYRE

About FVRR Fiverr International Ltd. no par value

Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Wiring and Translation, and Video and Animation among others.

About GYRE Gyre Therapeutics Inc.

Gyre Therapeutics Inc is a commercial-stage pharmaceutical company developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.

Share on Social Networks: